🌐 pelacarsen
Pelacarsen is an investigational antisense medicine developed by Novartis to lower lipoprotein(a), a cardiovascular risk factor, and is monitored globally for clinical-trial, regulatory, and commercial developments.
1
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Novartis shelves potential blockbuster pelacarsen as landmark study fails | active | Health | involved | 97% |